Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma.
about
Signaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cellsLeptin and its receptor in hematologic malignanciesThe association of diabetes and anti-diabetic medications with clinical outcomes in multiple myelomaBody size and multiple myeloma mortality: a pooled analysis of 20 prospective studies.The role of adiponectin in cancer: a review of current evidence.Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease.Regulatory pathways associated with bone loss and bone marrow adiposity caused by aging, chemotherapy, glucocorticoid therapy and radiotherapy.Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy.Trimming the fat: obesity and hematopoietic cell transplantation.The skinny on obesity and plasma cell myeloma: a review of the literature.Role of leptin and leptin receptors in hematological malignancies.Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives.Adiponectin as a biomarker linking obesity and adiposopathy to hematologic malignancies.Circulating resistin levels and risk of multiple myeloma in three prospective cohorts.Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can).Pro-inflammatory State in Monoclonal Gammopathy of Undetermined Significance and in Multiple Myeloma Is Characterized by Low Sialylation of Pathogen-Specific and Other Monoclonal Immunoglobulins.Development of a 3D bone marrow adipose tissue model.
P2860
Q26744596-49AEF843-82E9-4C8B-8A43-CA8D24C05FB6Q26765317-D3E128B4-B6F7-425E-8D51-8E0C94D46124Q33994341-F0943E4E-8EFB-46D1-85A2-E85F0AAEA060Q34052872-76649898-8970-4869-BFFF-BE06E09274E8Q34271986-D4EF0301-F93C-4BC8-B4BD-6A56E2128373Q35585973-D95688F4-A1DA-4DA0-B0D0-55B6A989052FQ36796392-D67D13C9-12AF-458E-8ED0-90E699F1ADFFQ37699183-2303FC1B-A633-4A80-BC6E-D283DDF751D9Q38056012-6728ABBD-559A-45E3-AD0E-88436621F1A5Q38211267-65A77CBE-5AEE-47D9-BEA0-37205D72F65DQ38298310-A9EC739F-BA54-4A99-9100-146E8A34EB75Q38482214-9B7AC213-8A9F-48E8-A968-E9080D738777Q38521988-7698C194-1A55-461C-B1DE-E9D92E7FE9B8Q40075362-1875D1E2-53BC-4B90-8CC0-910942C7C367Q44366740-B625203F-0174-4156-B0F5-0CFCF050B6B4Q47132349-980B61AC-37BC-4B14-8297-9AABF01B7F38Q49793251-DF4C737D-1FB8-4791-96DF-B810D45DDD98
P2860
Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Abnormal adipokine levels and ...... profiles in multiple myeloma.
@en
Abnormal adipokine levels and ...... profiles in multiple myeloma.
@nl
type
label
Abnormal adipokine levels and ...... profiles in multiple myeloma.
@en
Abnormal adipokine levels and ...... profiles in multiple myeloma.
@nl
prefLabel
Abnormal adipokine levels and ...... profiles in multiple myeloma.
@en
Abnormal adipokine levels and ...... profiles in multiple myeloma.
@nl
P2093
P1476
Abnormal adipokine levels and ...... profiles in multiple myeloma.
@en
P2093
Anders Waage
Anne T Brenne
Henrik Hjorth-Hansen
Janne E Reseland
Ole K Olstad
Per O Iversen
Sjur Reppe
Unni Syversen
P2860
P304
P356
10.1111/J.1600-0609.2009.01311.X
P577
2009-07-31T00:00:00Z